Federal Register / Vol. 75, No. 42 / Thursday, March 4, 2010 / Notices 9901 

Dated: February 26, 2010. 

Maryam I. Daneshvar, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2010–4510 Filed 3–3–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day-10–0736) 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 or send 

comments to Maryam I. Daneshvar, CDC 

Acting Reports Clearance Officer, 1600 

Clifton Road, MS D–74, Atlanta, GA 

30333 or send an e-mail to 

omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Human Smoking Behavior Study 

(OMB No. 0920–0736, exp. 3/31/2010)— 

Reinstatement with Change—National 

Center for Chronic Disease Prevention 

and Health Promotion (NCCDPHP), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

Cigarettes are currently ranked as fullflavor, light or ultralight on the basis of 

machine-measured levels of smoke 

toxins (yield categories). The machinebased methods approximate human 

smoking patterns under controlled 

conditions but may not accurately 

reflect conditions of actual use, 

moreover, public health data have not 

consistently shown differences in health 

outcomes among smokers of cigarettes 

of different machine-smoked yield 

categories. Comparison of cigarette 

smoke emissions using machinesmoking methods will continue until 

something superior is developed, 

therefore, machine-smoking must be 

adequately informed to yield results that 

better reflect human smoking behavior. 

In 2007, the Centers for Disease 

Control and Prevention (CDC) received 

OMB approval for a study designed to 

elucidate patterns of human smoking 

behavior, quantify biomarkers of 

exposure to smoke toxins under 

conditions of actual use, and determine 

how smoking behavior modifies the 

relationship between cigarette yield 

category, biomarkers of exposure, and 

measures of cardiovascular reactivity. 

The study has been a collaborative 

endeavor involving the National Center 

for Chronic Disease Prevention and 

Health Promotion (NCCDPHP) and the 

National Center for Environmental 

Health (NCEH). Information has been 

collected from adult smokers of fullflavor, light and ultralight cigarettes, 

however, the target number of 

respondents was not achieved during 

the initial approval period. 

CDC requests OMB approval to 

reinstate the information collection after 

the expiration date (OMB No. 0920– 

0736, exp. 3/31/2010) in order to meet 

recruitment goals and complete the data 

analysis as outlined in the original 

approval. Respondents will be asked to 

participate in a laboratory-based 

descriptive study of smoking behavior 

and analysis of biomarkers of exposure. 

Respondents will make two visits to a 

laboratory for measurements and 

complete a brief smoking diary during 

the one-day interval between the two 

laboratory visits. Indicators of smoking 

behavior such as ventilation poreblocking behavior, puff volume, puff 

duration, puff velocity and inter-puff 

interval will be assessed. Measures of 

exposure to be assessed include 

expired-air carbon monoxide boost, 

carcinogens, nicotine and its 

metabolites in urine, cotinine in saliva 

and solanesol in cigarette butts as an 

indicator of total smoke exposure. 

The goals of this project are to 

characterize the range of human 

smoking behavior for a variety of 

cigarette categories and machinesmoked yields, and to estimate the 

levels of biomarkers of exposure with 

the various cigarette styles. 

CDC Requests OMB approval for two 

years. During this period there will be 

a reduction in total burden due to the 

limited number of respondents needed 

to complete the study. No changes to the 

data collection instruments or the 

estimated burden per response are 

proposed. Participation in the study is 

voluntary. There are no costs to 

respondents other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of 

respondent Form name Number of respondents 

Number of responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Adult Smokers .................................. CATI Screener .................................. 150 1 5/60 13 

Visit 1 Screener ................................ 70 1 5/60 6 

Smoking Diary .................................. 61 1 10/60 10 

Laboratory Visit ................................ 61 2 1 122 

Total ........................................... ........................................................... ........................ ........................ ........................ 151 

mstockstill on DSKH9S0YB1PROD with NOTICES

9902 Federal Register / Vol. 75, No. 42 / Thursday, March 4, 2010 / Notices 

Dated: February 25, 2010. 

Maryam I. Daneshvar, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2010–4514 Filed 3–3–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–10–0009] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) publishes a list of 

information collection requests under 

review by the Office of Management and 

Budget (OMB) in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

requests, call the CDC Reports Clearance 

Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written 

comments to CDC Desk Officer, Office of 

Management and Budget, Washington, 

DC or by fax to (202) 395–5806. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

National Disease Surveillance 

Program I—Case Reports (OMB No. 

0920–0009, exp. 3/31/2010)— 

Revision—National Center for Zoonotic, 

Vector-borne, and Enteric Diseases 

(NCZVED), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

Formal surveillance of 16 separate 

reportable diseases has been ongoing to 

meet the public demand and scientific 

interest in accurate, consistent, 

epidemiologic data. These ongoing 

disease reports include: CreutzfeldtJakob Disease (CJD), Cyclospora, 

Dengue, Hantavirus, Kawasaki 

Syndrome, Legionellosis, Lyme disease, 

Malaria, Plague, Q Fever, Reye 

Syndrome, Tickborne Rickettsial 

Disease, Trichinosis, Tularemia, 

Typhoid Fever, and Viral Hepatitis. The 

Active Bacterial Surveillance (ABCs) 

forms were removed in 2007 and were 

approved as separate documents under 

OMB control number 0920–0802. Case 

report forms from state and territorial 

health departments enable CDC to 

collect demographic, clinical, and 

laboratory characteristics of cases of 

these diseases. This revision 

incorporates the removal of the ABCs 

surveillance forms and minor changes to 

the Malaria surveillance form. 

The purpose of the proposed study is 

to direct epidemiologic investigations, 

identify and monitor trends in 

reemerging infectious diseases or 

emerging modes of transmission, to 

search for possible causes or sources of 

the diseases, and develop guidelines for 

prevention and treatment. The data 

collected will also be used to 

recommend target areas most in need of 

vaccinations for selected diseases and to 

determine development of drug 

resistance. Because of the distinct 

nature of each of the diseases, the 

number of cases reported annually is 

different for each. There is no cost to 

respondents other than their time. The 

estimated annualized burden for this 

data collection is 11,441 hours. 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondent Form Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Epidemiologist ................................................. Tyhphoid fever ............................................... 55 6 20/60 

Viral hepatitis .................................................. 55 200 25/60 

CJD ................................................................ 20 2 20/60 

Cyclosporiasis ................................................ 55 10 15/60 

Dengue ........................................................... 55 182 15/60 

Hantavirus ...................................................... 40 3 20/60 

Kawasaki Syndrome ...................................... 55 8 15/60 

Legionellosis ................................................... 23 12 20/60 

Lyme Disease ................................................ 52 385 10/60 

Malaria ............................................................ 55 20 15/60 

Plague ............................................................ 11 1 20/60 

Q Fever .......................................................... 55 1 10/60 

Reye Syndrome ............................................. 50 1 20/60 

Tick-borne Rickettsia ...................................... 55 18 10/60 

Trichinosis ...................................................... 25 1 20/60 

Tularemia ....................................................... 55 2 20/60 

Dated: February 25, 2010. 

Maryam I. Daneshvar, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2010–4512 Filed 3–3–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Proposed Collection; Comment 

Request; The Agricultural Health 

Study: A Prospective Cohort Study of 

Cancer and Other Disease Among Men 

and Women in Agriculture (NCI) 

SUMMARY: In compliance with the 

requirement of Section 3506(c)(2)(A) of 

the Paperwork Reduction Act of 1995, 

for opportunity for public comment on 

proposed data collection projects, the 

National Cancer Institute (NCI), the 

National Institutes of Health (NIH) will 

publish periodic summaries of proposed 

projects to be submitted to the Office of 

Management and Budget (OMB) for 

review and approval. 

Proposed Collection: Title: The 

Agricultural Health Study: A 

Prospective Cohort Study of Cancer and 

Other Disease Among Men and Women 

in Agriculture (NCI) (OMB#: 0925– 

0406). Type of Information Collection 

Request: Revision. Need and Use of 

Information Collection: The purpose of 

this information collection is to 

mstockstill on DSKH9S0YB1PROD with NOTICES